Adapting diabetes clinical trials to embrace underrepresented communities
A lack of diversity among participants in clinical trials can exacerbate existing health disparities by limiting how applicable research findings…
Analysis
Mapping out strategies to overcome challenges in clinical research
BIOSECURE Act: Companies turn to US manufacturers
Obesity trial surge puts the focus back on decentralisation
Cassava Sciences: Phase III trials storm ahead amid controversy
Ushering in a new era of fit-for-purpose clinical endpoints for Rett syndrome
COBENFY for the Treatment of Schizophrenia, US
Pipeline Moves: Pfizer scores in Phase II cancer cachexia trial
